ArticleAdvances in therapy2024

Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.

Yang Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.